Healthcare

Changing the Game with Bernie Sanders

  Last month I got to spend some quality time with my fellow social democrat, Vermont Senator Bernie Sanders. As you may know, for decades, Bernie has been leading the fight for a universal healthcare system in the U.S. - a fight that was at the core of his inspiring campaign to be the Democratic ...

Weekly Market Review & Outlook (with Video) - Small Caps and Retailers Take the Lead - Energy Hits Moment of Truth

.... Broad Strength in the Nasdaq 100 .... IJR Bounces from Oversold Levels .... Small-cap Sector Leaders .... Healthcare and Consumer Discretionary Surge .... Retail SPDR Goes for a Bottom .... Starbucks, Nike and Disney Power XLY Higher .... SPY Bounces as QQQ Hits New High .... Four Sectors Corre ...

Dissecting the Medical Devices Group - Discount Brokers with Bullish Continuation Patterns - Banks, Gold, Utes and the 10-yr Yield

.... Medical Devices Group Leads Healthcare  .... Medtronic Bids to End Correction .... Abbot Labs Leads Medical Device Group .... Boston Scientific Bounces from Oversold Levels .... Four Medical Device Stocks (WAT, VAR, ALOG, CMD) .... First Oversold Readings Since Breakouts (BMY, BIIB) .... Disco ...

Rising Pharmaceutical Costs a Major Challenge for Managed Healthcare

The steep rise in pharmaceutical prices year over year is old news at this point. Even a number of generic drugs are going up in price, causing difficulties for insurers… The post Rising Pharmaceutical Costs a Major Challenge for Managed Healthcare appeared first on DrugPatentWatch Blog. The post ...

Should Price or Product Be the Determinant in Pharmaceutical Competition?

This article was originally published at https://www.drugpatentwatch.com/blog/price-product-determinant-pharmaceutical-competition/ Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price a ...

A stock-picker’s TFSA for long-term growth

Sam Tanny AGE: 21PLACE: MontrealTFSA TOTAL: $25,415STRATEGY: Growth and blue-chip stocks Me and My TFSA   Sam Tanny, 21, of Montreal, is a university student in finance. He started saving in his TFSA two years ago but he only started picking stocks for his portfolio last year. It’s now wor ...

Weekly Market Review & Outlook - Junk Bonds Fall Hard

.... Risk-on versus Risk-off on One PerfChart .... Junk Bond ETF Falls Most Since August .... The Oxymoronic Nature of Technical Analysis  .... SPY Hovers Near its Highs .... RSI Moves into Oversold Zone for IJR .... Finance, Industrials and Healthcare Lead Pullback .... Utilities SPDR Hit 52-week ...

Weekly Market Review & Outlook (w/ video) - Junk Bonds Fall Hard

.... Risk-on versus Risk-off on One PerfChart .... Junk Bond ETF Falls Most Since August .... The Oxymoronic Nature of Technical Analysis  .... SPY Hovers Near its Highs .... RSI Moves into Oversold Zone for IJR .... Finance, Industrials and Healthcare Lead Pullback .... Utilities SPDR Hit 52-week ...

That midnight snack may be killing you, study finds

If you’re one who likes a midnight snack to tide you over until breakfast, the news isn’t great, as research shows that eating just before bed is a risk factor for heart disease and diabetes. The perils of staying up late aren’t just related to a lack of sleep and grumbling about it the next ...

Q3 Share Price Performance in 2017 – Part 1

Very High Volatility and Mixed Performance The key statistic from analysis of the 9-month share price performance is that 52 of 115 companies (45%) had share price changes greater than 40%. For most of my personal biotech investing, I look for potential doubles in the next 12 months – it is al ...